"10.1371_journal.pone.0137110","plos one","2015-09-10T00:00:00Z","Eva M Schmidt; Constanze Wiek; Oliver T Parkinson; Katharina Roellecke; Marcel Freund; Michael Gombert; Nadine Lottmann; Charles A Steward; Christof M Kramm; Vladimir Yarov-Yarovoy; Allan E Rettie; Helmut Hanenberg","Department of Pediatric Hematology, Oncology and Clinical Immunology, Children’s Hospital, Heinrich Heine University, 40225 Düsseldorf, Germany; Department of Otorhinolaryngology and Head/Neck Surgery, Heinrich Heine University, 40225 Düsseldorf, Germany; Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, WA 98195, United States of America; Wellcome Trust Sanger Institute, Cambridge, United Kingdom; Division of Pediatric Hematology and Oncology, Department of Child and Adolescent Health, University of Göttingen, 37099 Göttingen, Germany; Departments of Physiology and Membrane Biology, University of California Davis, Davis, CA 95616, United States of America; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, United States of America; Department of Pediatrics III, University Children’s Hospital Essen, University of Duisburg-Essen, 45122 Essen, Germany","Conceived and designed the experiments: EMS CW CMK AER HH. Performed the experiments: EMS CW OTP KR MF MG NL. Analyzed the data: EMS CW OTP KR CMK AER HH. Contributed reagents/materials/analysis tools: CAS CMK VYY. Wrote the paper: EMS CW OTP KR MF MG NL CAS CMK AER HH.","HH may receive royalties based on a license agreement between Indiana University, Indianapolis, USA, and Takara Shuzo Inc., Kyoto, Japan, on the sales and usage of Retronectin CH-296 in transduction protocols. The other authors declare no competing financial interests. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","09","Eva M Schmidt","EMS",12,TRUE,5,7,7,11,TRUE,TRUE,FALSE,0,NA,FALSE
